UNIGE document Scientific Article
previous document  unige:7082  next document
add to browser collection
Title

Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial

Authors
Ananworanich, Jintanat
Nuesch, Reto
Le Braz, Michelle
Chetchotisakd, Ploechan
Vibhagool, Asda
Wicharuk, Saijai
Ruxrungtham, Kiat
Furrer, Hansjakob
show hidden authors show all authors [1 - 21]
Published in AIDS. 2003, vol. 17, no. 15, p. F33-37
Abstract BACKGROUND: Scheduled treatment interruptions are being evaluated in an effort to decrease costs and side effects of highly active antiretroviral therapy (HAART). A schedule of 1 week on and 1 week off therapy offers the promise of 50% less drug exposure with continuously undetectable HIV RNA concentration. METHODS: In the Staccato study 600 patients on successful HAART were to be randomized to either continued therapy, CD4-guided therapy, or one week on, one week off therapy. A scheduled preliminary analysis evaluated effectiveness in the 1-week-on-1-week-off arm. RESULTS: Of 36 evaluable patients, 19 (53%) had two successive HIV RNA concentrations > 500 copies/ml at the end of the week off therapy, and were classified as virological failure. Most of those who failed took didanosine, stavudine, saquinavir, and ritonavir (11 patients). In these patients, there was no evidence of mutations suggestive of drug resistance, and plasma saquinavir levels were within the expected range. Two of three patients failing on triple nucleotides had drug resistance mutations, but nonetheless responded to reintroduction of triple nucleotide therapy. One of two patients taking nevirapine, and one of eight taking efavirenz, also failed. Both had resistance mutations at the time of failure, but not at baseline. CONCLUSIONS: The 1-week-on-1-week-off schedule, as tested in the Staccato study, showed an unacceptably high failure rate and was therefore terminated.
Keywords Anti-HIV Agents/administration & dosageAntiretroviral Therapy, Highly Active/ methodsDidanosine/administration & dosageDrug Administration ScheduleDrug Resistance, ViralGenes, ViralGenotypeHIV Infections/ drug therapy/immunologyHumansMutationRNA, Viral/analysisRitonavir/administration & dosageSaquinavir/administration & dosageStavudine/administration & dosageTreatment Failure
Identifiers
PMID: 14523294
Full text
Structures
Citation
(ISO format)
ANANWORANICH, Jintanat et al. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. In: AIDS, 2003, vol. 17, n° 15, p. F33-37. https://archive-ouverte.unige.ch/unige:7082

109 hits

1 download

Update

Deposited on : 2010-06-21

Export document
Format :
Citation style :